Rani Therapeutics Holdings (RANI) Net Shares Issued and Repurchased (2021 - 2026)

Rani Therapeutics Holdings has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at $192512.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 83.82% year-over-year to $192512.0 in Q1 2026; TTM through Mar 2026 was $192512.0, a 83.82% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, up 6.41% from the prior year.
• Net Shares Issued and Repurchased was $192512.0 for Q1 2026 at Rani Therapeutics Holdings, down from $4.5 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.6 billion in Q4 2022, with the low at $192512.0 in Q1 2026.
• Average Net Shares Issued and Repurchased over 5 years is $230.6 million, with a median of $3.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased sank 99.8% in 2023, then surged 33.08% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.6 billion in 2022, then tumbled by 99.8% to $3.2 million in 2023, then surged by 33.08% to $4.2 million in 2024, then rose by 6.41% to $4.5 million in 2025, then plunged by 95.7% to $192512.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $192512.0 (Q1 2026), $4.5 million (Q4 2025), and $1.2 million (Q1 2025), per Business Quant data.